Trademark: 90264063
Status Date
Monday, March 4, 2024
Filing Date
Monday, October 19, 2020
Published for Opposition
Tuesday, June 1, 2021
Abandoned Date
Monday, March 4, 2024
44 Medical testing for diagnostic or treatment purposes; Medical testing services, namely, next-generation sequencing testing for detection and diagnosis of blood, bone marrow, and lymph node cancers, namely, leukemias and lymphomas
Mar 4, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 4, 2024
Abandonment - No Use Statement Filed
Nov 29, 2023
Teas Change Of Correspondence Received
Nov 29, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 29, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 20, 2023
Sou Extension 4 Granted
Jul 20, 2023
Sou Extension 4 Filed
Jul 20, 2023
Sou Teas Extension Received
Jan 24, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 20, 2023
Sou Extension 3 Granted
Jan 20, 2023
Sou Extension 3 Filed
Jan 20, 2023
Sou Teas Extension Received
Jul 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 27, 2022
Sou Extension 2 Granted
Jul 27, 2022
Sou Extension 2 Filed
Jul 27, 2022
Sou Teas Extension Received
Jan 22, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 20, 2022
Sou Extension 1 Granted
Jan 20, 2022
Sou Extension 1 Filed
Jan 20, 2022
Sou Teas Extension Received
Jul 27, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 1, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 1, 2021
Published For Opposition
May 12, 2021
Notification Of Notice Of Publication E-Mailed
Apr 27, 2021
Approved For Pub - Principal Register
Mar 25, 2021
Examiner's Amendment Entered
Mar 25, 2021
Notification Of Examiners Amendment E-Mailed
Mar 25, 2021
Examiners Amendment E-Mailed
Mar 25, 2021
Examiners Amendment -Written
Mar 18, 2021
Assigned To Examiner
Dec 8, 2020
New Application Office Supplied Data Entered
Oct 22, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
